Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)

被引：0
|
作者：
Hideki Kato
Masaomi Nangaku
Hideki Hirakata
Takashi Wada
Terumasa Hayashi
Hiroshi Sato
Yasushi Yamazaki
Takao Masaki
Tatsuo Kagimura
Hiroyasu Yamamoto
Hiroki Hase
Masahiro Kamouchi
Enyu Imai
Kyoichi Mizuno
Manabu Iwasaki
Tadao Akizawa
Yoshiharu Tsubakihara
Shoichi Maruyama
Ichiei Narita
机构：
[1] The University of Tokyo Graduate School of Medicine,Division of Nephrology and Endocrinology
[2] Fukuoka Renal Clinic,Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences
[3] Kanazawa University,Department of Kidney Disease and Hypertension
[4] Osaka General Medical Centre,Division of Clinical Pharmacology and Therapeutics
[5] Tohoku University Graduate School of Pharmaceutical Sciences and Faculty of Pharmaceutical Sciences,Department of Nephrology and Rheumatology
[6] Kagawa Prefectural Central Hospital,Department of Nephrology
[7] Hiroshima University Hospital,Department of Internal Medicine
[8] Translational Research Informatics Center,Division of Nephrology
[9] Foundation Biomedical Research and Innovation,Department of Health Care Administration and Management, Graduate School of Medical Sciences
[10] Atsugi City Hospital,Nakayamadera Imai Clinic, Takarazuka, Hyogo, Department of Nephrology
[11] Toho University Ohashi Medical Center,Department of Computer and Information Science
[12] Kyushu University,Division of Nephrology, Department of Medicine
[13] Fujita Health University Toyoake,Course of Safety Management in Health Care Sciences, Graduate School of Health Care Sciences
[14] Mitsukoshi Health and Welfare Foundation,Department of Nephrology
[15] Seikei University,Division of Clinical Nephrology and Rheumatology
[16] Showa University School of Medicine,undefined
[17] Jikei Institute,undefined
[18] Nagoya University Graduate School of Medicine,undefined
[19] Niigata University Graduate School of Medical and Dental Sciences,undefined
来源：
Clinical and Experimental Nephrology | 2018年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：85 / 86
页数：1
相关论文
共 50 条
  • [41] Role of parathyroidectomy on anemia control and erythropoiesis-stimulating agent need in secondary hyperparathyroidism of chronic kidney disease. A retrospective study in 30 hemodialysis patients
    Conzo, Giovanni
    Perna, Alessandra
    Della Pietra, Cristina
    Esposito, Daniela
    Nunziata, Anna
    Palazzo, Antonietta
    Pizza, Alessandra
    Satta, Ersilia
    Sciascia, Valerio
    Santini, Luigi
    ANNALI ITALIANI DI CHIRURGIA, 2013, 84 (01) : 25 - 31
  • [42] Erythropoietin-Stimulating Agent Requirements for Anemia in Renal Transplant Recipients vs. Chronic Kidney Disease Patients
    Chang, S.
    Regulagadda, A.
    Gudleski, G.
    Zachariah, M.
    Venuto, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 291 - 291
  • [43] Cardiovascular Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients With Chronic Kidney Disease Incident to or Not Receiving Dialysis: Pooled Subgroup Analysis of Four Phase 3 Studies
    Esposito, Ciro
    Barratt, Jonathan
    Dellanna, Frank
    Portoles, Jose
    Choukroun, Gabriel
    De Nicola, Luca
    Reusch, Michael
    Young, James
    Jiletcovici, Alina
    Dimkovicl, Nada
    SWISS MEDICAL WEEKLY, 2022, 152 : 23S - 24S
  • [44] ANEMIA MANAGEMENT AND OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A STUDY FROM A CLINICAL RESEARCH CENTER FOR END-STAGE RENAL DISEASE IN KOREA
    Sun-Hee, Park
    Owen, Kwon
    Yong-Lim, Kim
    NEPHROLOGY, 2014, 19 : 21 - 22
  • [45] High Target Hemoglobin With Erythropoiesis-Stimulating Agents Has Advantages in the Renal Function of Non-Dialysis Chronic Kidney Disease Patients (vol 16, pg 529, 2012)
    Tsubakihara, Y.
    Gejyo, F.
    Nishi, S.
    THERAPEUTIC APHERESIS AND DIALYSIS, 2014, 18 (04) : 370 - 370
  • [46] Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies
    Jonathan Barratt
    Frank Dellanna
    Jose Portoles
    Gabriel Choukroun
    Luca De Nicola
    James Young
    Nada Dimković
    Michael Reusch
    Advances in Therapy, 2023, 40 (4) : 1546 - 1559
  • [47] Roxadustat vs. Erythropoiesis-Stimulating Agents and the Effect on Lipid Profile in Dialysis-Dependent Patients With Anemia of Renal Disease: A Meta-Analysis of Phase 3 Randomized Controlled Trials
    Mekraksakit, Poemlarp
    Leelaviwat, Natnicha
    Dejhansathit, Siroj
    Del Rio-Pertuz, Gaspar
    Cheungpasitporn, Wisit
    Benjanuwattra, Juthipong
    Duangkham, Samapon
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 245 - 245
  • [48] Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies
    Barratt, Jonathan
    Dellanna, Frank
    Portoles, Jose
    Choukroun, Gabriel
    De Nicola, Luca
    Young, James
    Dimkovic, Nada
    Reusch, Michael
    ADVANCES IN THERAPY, 2023, 40 (04) : 1546 - 1559
  • [49] Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: Rationale and design of the ASsessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial
    Kenji Ueshima
    Masato Kasahara
    Daisuke Koya
    Tetsuya Babazono
    Tosiya Sato
    Miyuki Imamoto
    Shinji Yasuno
    Akira Fujimoto
    Shiro Tanaka
    Genjiro Kimura
    Kazuwa Nakao
    Clinical and Experimental Nephrology, 2013, 17 : 211 - 217
  • [50] Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: Rationale and design of the ASsessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial
    Ueshima, Kenji
    Kasahara, Masato
    Koya, Daisuke
    Babazono, Tetsuya
    Sato, Tosiya
    Imamoto, Miyuki
    Yasuno, Shinji
    Fujimoto, Akira
    Tanaka, Shiro
    Kimura, Genjiro
    Nakao, Kazuwa
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (02) : 211 - 217
12345